[Selective targetting of antiviral agents to the liver].
D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002914:Chylomicrons / Q000627:therapeutic use*; D004337:Drug Carriers; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage*; D006521:Hepatitis, Chronic / Q000628:therapy*; D006801:Humans; D007065:Idoxuridine / Q000008:administration & dosage; D019259:Lamivudine; D011355:Prodrugs / Q000008:administration & dosage; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage; D016047:Zalcitabine / Q000008:administration & dosage / Q000031:analogs & derivatives
D000998:Antiviral Agents; D002914:Chylomicrons; D004337:Drug Carriers; D011355:Prodrugs; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D016047:Zalcitabine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D007065:Idoxuridine
Selectieve 'targeting' van antivirale middelen naar de lever.